Health related quality of life after conservative or invasive treatment of inducible postinfarction ischaemia. DANAMI study group
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Health related quality of life after conservative or invasive treatment of inducible postinfarction ischaemia. DANAMI study group. / Mortensen, O S; Madsen, J K; Haghfelt, T; Grande, P; Saunamäki, K; Haunsø, S; Hjelms, E; Arendrup, H.
In: Heart (British Cardiac Society), Vol. 84, No. 5, 11.2000, p. 535-40.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Health related quality of life after conservative or invasive treatment of inducible postinfarction ischaemia. DANAMI study group
AU - Mortensen, O S
AU - Madsen, J K
AU - Haghfelt, T
AU - Grande, P
AU - Saunamäki, K
AU - Haunsø, S
AU - Hjelms, E
AU - Arendrup, H
PY - 2000/11
Y1 - 2000/11
N2 - OBJECTIVE: To assess health related quality of life in patients with inducible postinfarction ischaemia.DESIGN: A questionnaire based follow up study on patients randomised to conservative or invasive treatment because of postinfarction ischaemia.SETTING: Seven county hospitals in eastern Denmark and the Heart Centre, National University Hospital, Copenhagen, Denmark.PATIENTS: 113 patients with inducible postinfarction ischaemia: 51 were randomised to conservative treatment and 62 to invasive treatment. Average follow up time was three years (19-57 months).MAIN OUTCOME MEASURES: SF-36, Rose angina and dyspnoea questionnaire, drug use, lifestyle, and cognitive function.RESULTS: Invasively treated patients scored better on the SF-36 scales of physical functioning (p = 0.03) and on role-physical (p = 0.04) and physical component scales (p = 0.05) and took significantly less anti-ischaemic drug treatment. Angina occurred in 18% of the invasively treated patients and 31% of the conservatively treated patients (p = 0.09). However, more invasively treated patients suffered from concentration difficulties (18% v 4%; p = 0.04).CONCLUSIONS: Patients who were treated invasively had better health related quality of life scores in the physical variables compared with conservatively treated patients. However, a larger proportion of invasively treated patients had concentration difficulties.
AB - OBJECTIVE: To assess health related quality of life in patients with inducible postinfarction ischaemia.DESIGN: A questionnaire based follow up study on patients randomised to conservative or invasive treatment because of postinfarction ischaemia.SETTING: Seven county hospitals in eastern Denmark and the Heart Centre, National University Hospital, Copenhagen, Denmark.PATIENTS: 113 patients with inducible postinfarction ischaemia: 51 were randomised to conservative treatment and 62 to invasive treatment. Average follow up time was three years (19-57 months).MAIN OUTCOME MEASURES: SF-36, Rose angina and dyspnoea questionnaire, drug use, lifestyle, and cognitive function.RESULTS: Invasively treated patients scored better on the SF-36 scales of physical functioning (p = 0.03) and on role-physical (p = 0.04) and physical component scales (p = 0.05) and took significantly less anti-ischaemic drug treatment. Angina occurred in 18% of the invasively treated patients and 31% of the conservatively treated patients (p = 0.09). However, more invasively treated patients suffered from concentration difficulties (18% v 4%; p = 0.04).CONCLUSIONS: Patients who were treated invasively had better health related quality of life scores in the physical variables compared with conservatively treated patients. However, a larger proportion of invasively treated patients had concentration difficulties.
KW - Adult
KW - Aged
KW - Angioplasty, Balloon, Coronary
KW - Coronary Artery Bypass
KW - Female
KW - Follow-Up Studies
KW - Health Status Indicators
KW - Humans
KW - Life Style
KW - Male
KW - Middle Aged
KW - Myocardial Infarction/complications
KW - Myocardial Ischemia/etiology
KW - Psychometrics
KW - Quality of Life
KW - Treatment Outcome
U2 - 10.1136/heart.84.5.535
DO - 10.1136/heart.84.5.535
M3 - Journal article
C2 - 11040017
VL - 84
SP - 535
EP - 540
JO - Heart
JF - Heart
SN - 1355-6037
IS - 5
ER -
ID: 347802578